Data / Form D filings / BIOSIGNIA INC
BIOSIGNIA INC: Form D filing
BIOSIGNIA INC, a biotechnology company in Durham, NC, filed a Form D with the SEC in 2012. The latest, on July 13, 2012, reports $328,750 sold of a $328,750 offering to 1 investor.
Find out what BIOSIGNIA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1822 East NC Highway 54, Suite 350, Durham, NC, 27713
- Phone
- (919) 933-2021
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1098019
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2012 | New notice | $328,750 | $328,750 | $0 | 1 | Jun 28, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas Colin Martin | Director | |
| Guizhou Jose Hu | Executive Officer | |
| Timothy David Smith | Director | |
| Gregory Jose Rossi | Executive Officer | |
| Martin Colin Hart | Director | |
| T. Colin Campbell | Director | |
| A. Jose Cortina | Executive Officer | |
| C. David Smith | Director | |
| Robert Colin Mauldin | Director | |
| Helen Colin Laughery | Director | |
| John Williams | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jul 9, 2012 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOSIGNIA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.